Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
INS50589 Intravenous Infusion
DRUG
2 trials
Sponsors
Merck Sharp & Dohme LLC
Conditions
Cardiovascular Disease
Coronary Disease
Phase 1
Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers
Completed
NCT00099450
Merck Sharp & Dohme LLC
Cardiovascular Disease
Start: 2004-12-31
End: 2005-03-31
Target: 48
Updated: 2015-01-21
Phase 2
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Terminated
NCT00316212
Merck Sharp & Dohme LLC
Coronary Disease
Start: 2006-04-30
Target: 160
Updated: 2016-11-18